CONy 2020 ALS Program

*This program is subject to change

ALS should not be considered a neuromuscular disorder
Host: Giancarlo Logroscino, Italy
Yes: Michael van Es, The Netherlands 
No: Monica Povedano Panades, Spain

ALS is a prion-like disease

Patients should set the agenda for therapeutic trials in ALS
Host: Albert Ludolph, Germany
Yes: Paul Wicks, USA

The study of mice has been detrimental to developing therapy for ALS
Host: Peter Bede, Ireland
No: Elizabeth Fisher, UK
Discussion and rebuttals